Alnylam Pharmaceuticals logo

Senior Director, Clinical Portfolio Technology

Alnylam Pharmaceuticals
Full-time
Remote friendly (Cambridge, MA)
United States
$226,800 - $306,800 USD yearly
IT

Want to see how your resume matches up to this job? A free trial of our JobsAI will help! With over 2,000 biopharma executives loving it, we think you will too! Try it now — JobsAI.

Role Summary

Senior Director, Clinical Portfolio Technology – strategic technology leader driving strategy, delivery, and governance of platforms supporting Clinical Delivery, Portfolio Management, and DSSE. Translates business strategy into validated, compliant, and AI-enabled capabilities to accelerate study execution, optimize portfolio analytics, and enable advanced data science and statistical insights.

Responsibilities

  • Strategic Partnership & Engagement: Serve as a thought partner to Clinical Ops, Study Management, Portfolio/PPM leadership, and DSSE; build collaborative relationships to anticipate needs, align technology roadmaps, and drive shared outcomes.
  • Clinical Delivery & Portfolio Technology Leadership: Own product and platform roadmaps for clinical trial execution, study management, and portfolio analytics; define capability priorities and success metrics; govern scope, risk, dependencies, and budgets; drive value realization and cost optimization.
  • DSSE Enablement: Partner with DSSE to enable analytics, statistical computing, and real-world evidence generation; integrate data standards and support data stewardship, automation, and AI-enabled insights; champion centralized dashboards and data visualization.
  • Portfolio Analytics & Decision Support: Provide data-driven insights, scenario modeling, and resource forecasting; enable robust portfolio prioritization and reporting.
  • Standardization & Governance: Standardize ways of working in alignment with IT Operating Model; champion test automation, resilient operations, information security, and technology governance for clinical and DSSE platforms.

Qualifications

  • Required: Advanced degree in Information Technology, Data Science, Computer Science, or related field with specialized knowledge in clinical development and analytics.
  • 12–15+ years in life-sciences technology with 5–8+ years leading delivery for Clinical platforms in GxP environments.
  • Deep expertise in 21 CFR Part 11, EU Annex 11, ICH E6(R2); demonstrated inspection-readiness leadership and strong CSV/CSA practices.
  • Demonstrated vendor/SOW management with major platform providers (e.g., Veeva, Medidata).
  • Strong program/portfolio leadership across complex multi-workstream initiatives; fluency in Agile and product operating models.
  • Excellent executive communication and stakeholder engagement; strong analytical and problem-solving skills with a track record of operational excellence and innovation.

Preferred

  • Experience with RBQM/centralized monitoring (e.g., CluePoints).
  • Knowledge of CDISC standards, E2B(R3), portfolio analytics, and data visualization.
  • Working knowledge of integration patterns (e.g., Boomi), cloud (AWS), automated testing, and data governance in regulated environments.